US Archives - Page 4 of 137 - European Medical Journal

Patient receiving pulmonary tuberculosis therapy with rifampicin exposure focus

Rifampicin Levels Shape Tuberculosis Treatment Success

Higher rifampicin exposure accelerated bacillary clearance and predicted pulmonary tuberculosis treatment outcomes in patients.

Hospital burden of thrombotic events in systemic lupus erythematosus

Nationwide Study Exposes Thrombosis Burden in SLE

Thrombotic events remain a major driver of mortality and morbidity among patients with systemic lupus erythematosus.

Expert Insights on HER2-Mutant NSCLC

Dr. Joshua Sabari explores recent advances in the treatment of HER2-mutant non-small cell lung cancer, including a newly FDA-approved option…

AMJ Oncology 2.1 [Supplement 3] 2025

The FDA has now approved zongertinib, a tyrosine kinase inhibitor, for the treatment of adult patients with unresectable or metastatic…

cancer survivor eating healthy meal while seated indoors

Prolonged Sitting Raises Mortality, Nutrition May Protect in Cancer

Prolonged sitting increases mortality risk in cancer survivors, but a healthy diet may significantly reduce that risk.

Therapeutic hypothermia treatment concept for traumatic brain injury patient

Controversial Role of Therapeutic Hypothermia in Traumatic Brain Injury

The controversial role of therapeutic hypothermia in traumatic brain injury continues to divide clinicians, as recent findings reveal conflicting effects on survival and neurological outcomes.

Children playing happily after hepatitis C treatment

Pediatric Hepatitis C Fully Treated with Sofosbuvir

A recent study has demonstrated the high efficacy and favorable safety profile of sofosbuvir-based regimens in treating hepatitis C virus (HCV) in children aged 5 to 17 years.

sleep apnea concept

GLP-1 Therapy Improves Survival in Diabetes and Sleep Apnea

Patients with type 2 diabetes and obstructive sleep apnea experienced significantly greater survival benefits from GLP-1 receptor agonist therapy than those without sleep apnea.

Concept image showing weight measurement and inflammation control in psoriatic arthritis treatment

Weight Gain Rates Stabilize After TNF Inhibitor Initiation

Tumor necrosis factor inhibitor therapy in patients with psoriatic arthritis does not appear to accelerate weight gain beyond expected age-related trends, according to findings from a retrospective cohort study.

AI visualization predicting facial aging from tobacco use

AI Model Predicts Facial Aging from Tobacco Use

A new AI-based simulator integrating dermatologist expertise predicts how tobacco use accelerates facial aging over 15 years.